Last reviewed · How we verify

Local application of collagen-gentamicin

Region Örebro County · Phase 1 active Small molecule Quality 0/100

Local application of collagen-gentamicin is a Small molecule drug developed by Region Örebro County. It is currently in Phase 1 development. Also known as: Collatamp-G.

At a glance

Generic nameLocal application of collagen-gentamicin
Also known asCollatamp-G
SponsorRegion Örebro County
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Local application of collagen-gentamicin

What is Local application of collagen-gentamicin?

Local application of collagen-gentamicin is a Small molecule drug developed by Region Örebro County.

Who makes Local application of collagen-gentamicin?

Local application of collagen-gentamicin is developed by Region Örebro County (see full Region Örebro County pipeline at /company/region-rebro-county).

Is Local application of collagen-gentamicin also known as anything else?

Local application of collagen-gentamicin is also known as Collatamp-G.

What development phase is Local application of collagen-gentamicin in?

Local application of collagen-gentamicin is in Phase 1.

Related